| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amides | 7 | 2024 | 71 | 3.620 |
Why?
|
| Carboxylic Ester Hydrolases | 7 | 2014 | 58 | 1.810 |
Why?
|
| Cell Movement | 5 | 2024 | 655 | 1.430 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2024 | 56 | 1.420 |
Why?
|
| Lung Neoplasms | 3 | 2024 | 495 | 1.330 |
Why?
|
| Protein Prenylation | 4 | 2013 | 12 | 1.180 |
Why?
|
| Antineoplastic Agents | 5 | 2024 | 1019 | 1.150 |
Why?
|
| Apoptosis | 5 | 2025 | 1568 | 1.060 |
Why?
|
| MAP Kinase Signaling System | 2 | 2025 | 196 | 0.960 |
Why?
|
| Focal Adhesions | 1 | 2025 | 16 | 0.930 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2025 | 47 | 0.880 |
Why?
|
| Monomeric GTP-Binding Proteins | 1 | 2023 | 8 | 0.790 |
Why?
|
| Breast Neoplasms | 2 | 2025 | 1723 | 0.760 |
Why?
|
| Protein Methyltransferases | 3 | 2011 | 6 | 0.740 |
Why?
|
| Peptidyl-Dipeptidase A | 8 | 2006 | 35 | 0.690 |
Why?
|
| Cell Survival | 7 | 2025 | 945 | 0.680 |
Why?
|
| S-Adenosylmethionine | 6 | 2004 | 41 | 0.630 |
Why?
|
| Houseflies | 7 | 1997 | 7 | 0.600 |
Why?
|
| Cell Proliferation | 3 | 2023 | 1455 | 0.570 |
Why?
|
| Mutation | 3 | 2024 | 1177 | 0.570 |
Why?
|
| Cell Line, Tumor | 7 | 2024 | 2676 | 0.550 |
Why?
|
| Chorioallantoic Membrane | 1 | 2016 | 11 | 0.510 |
Why?
|
| Spheroids, Cellular | 3 | 2025 | 37 | 0.500 |
Why?
|
| Embryo, Nonmammalian | 1 | 2016 | 59 | 0.500 |
Why?
|
| Actins | 1 | 2017 | 164 | 0.490 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2016 | 62 | 0.490 |
Why?
|
| Neovascularization, Physiologic | 1 | 2016 | 80 | 0.480 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 133 | 0.450 |
Why?
|
| Cysteine | 3 | 2024 | 103 | 0.430 |
Why?
|
| Liver | 3 | 2008 | 511 | 0.400 |
Why?
|
| Neoplasms | 2 | 2023 | 1377 | 0.400 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2012 | 6 | 0.370 |
Why?
|
| Subtilisins | 5 | 1999 | 12 | 0.370 |
Why?
|
| Carboxylesterase | 2 | 2011 | 5 | 0.370 |
Why?
|
| Benzopyrans | 1 | 2012 | 25 | 0.360 |
Why?
|
| Sus scrofa | 2 | 2011 | 19 | 0.360 |
Why?
|
| Curcumin | 1 | 2013 | 118 | 0.360 |
Why?
|
| Sulfinic Acids | 1 | 2011 | 5 | 0.350 |
Why?
|
| Lung | 2 | 2026 | 492 | 0.350 |
Why?
|
| cdc42 GTP-Binding Protein | 2 | 2024 | 25 | 0.350 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 218 | 0.350 |
Why?
|
| Humans | 19 | 2026 | 43102 | 0.340 |
Why?
|
| Hydrolysis | 9 | 2011 | 97 | 0.340 |
Why?
|
| Animals | 33 | 2016 | 16992 | 0.330 |
Why?
|
| Enzyme Inhibitors | 4 | 2011 | 458 | 0.320 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2025 | 307 | 0.310 |
Why?
|
| Methylation | 6 | 2012 | 119 | 0.290 |
Why?
|
| Kinetics | 8 | 2013 | 695 | 0.270 |
Why?
|
| Substrate Specificity | 7 | 2011 | 219 | 0.260 |
Why?
|
| Colorectal Neoplasms | 1 | 2013 | 512 | 0.260 |
Why?
|
| Nerve Tissue Proteins | 6 | 2004 | 386 | 0.260 |
Why?
|
| Haloperidol | 2 | 2019 | 36 | 0.250 |
Why?
|
| Amino Acid Sequence | 11 | 2008 | 1180 | 0.240 |
Why?
|
| Aromatase Inhibitors | 1 | 2025 | 19 | 0.230 |
Why?
|
| Cell Culture Techniques | 1 | 2026 | 152 | 0.230 |
Why?
|
| Structure-Activity Relationship | 6 | 2019 | 506 | 0.230 |
Why?
|
| Pituitary Hormones | 4 | 1999 | 7 | 0.230 |
Why?
|
| Neuropeptides | 2 | 1997 | 64 | 0.220 |
Why?
|
| Organophosphorus Compounds | 1 | 2005 | 37 | 0.220 |
Why?
|
| Rats | 14 | 2014 | 3735 | 0.220 |
Why?
|
| Receptors, Dopamine D2 | 3 | 2014 | 83 | 0.220 |
Why?
|
| Dipeptidyl-Peptidases and Tripeptidyl-Peptidases | 2 | 1994 | 3 | 0.210 |
Why?
|
| Dyskinesia, Drug-Induced | 1 | 2003 | 8 | 0.210 |
Why?
|
| Molecular Sequence Data | 10 | 2008 | 1542 | 0.210 |
Why?
|
| Cystine | 1 | 2003 | 14 | 0.210 |
Why?
|
| Environmental Exposure | 1 | 2026 | 256 | 0.200 |
Why?
|
| Parkinsonian Disorders | 2 | 2002 | 42 | 0.200 |
Why?
|
| Tremor | 2 | 2000 | 9 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2025 | 299 | 0.200 |
Why?
|
| Rats, Sprague-Dawley | 8 | 2014 | 1766 | 0.190 |
Why?
|
| Reactive Oxygen Species | 1 | 2025 | 532 | 0.190 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 291 | 0.180 |
Why?
|
| Phosphorylation | 1 | 2024 | 986 | 0.180 |
Why?
|
| Dopamine Antagonists | 3 | 2014 | 48 | 0.170 |
Why?
|
| Parkinson Disease, Secondary | 1 | 2000 | 12 | 0.170 |
Why?
|
| Swine | 2 | 2012 | 212 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 4 | 1999 | 185 | 0.160 |
Why?
|
| Enzyme Precursors | 1 | 1999 | 12 | 0.150 |
Why?
|
| Receptors, sigma | 1 | 2019 | 16 | 0.150 |
Why?
|
| Azepines | 1 | 2019 | 22 | 0.150 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2014 | 1124 | 0.150 |
Why?
|
| Hemolymph | 2 | 1997 | 8 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2019 | 157 | 0.140 |
Why?
|
| Brain | 6 | 2005 | 1472 | 0.130 |
Why?
|
| Pseudopodia | 1 | 2017 | 17 | 0.130 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 34 | 0.130 |
Why?
|
| Pentanes | 1 | 2016 | 5 | 0.130 |
Why?
|
| Hemiterpenes | 1 | 2016 | 7 | 0.130 |
Why?
|
| Butadienes | 1 | 2016 | 29 | 0.130 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2017 | 50 | 0.130 |
Why?
|
| Chick Embryo | 1 | 2016 | 79 | 0.130 |
Why?
|
| Chromatography, Gel | 3 | 2005 | 51 | 0.120 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 508 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2016 | 1621 | 0.120 |
Why?
|
| Sodium Chloride | 1 | 1996 | 54 | 0.120 |
Why?
|
| Endopeptidases | 1 | 1996 | 64 | 0.120 |
Why?
|
| Protein Binding | 3 | 2017 | 1082 | 0.120 |
Why?
|
| Molecular Structure | 2 | 2014 | 570 | 0.110 |
Why?
|
| Polymers | 1 | 2016 | 155 | 0.110 |
Why?
|
| Zebrafish | 1 | 2016 | 146 | 0.110 |
Why?
|
| Cell Death | 2 | 2014 | 278 | 0.110 |
Why?
|
| GTP-Binding Protein beta Subunits | 1 | 2014 | 15 | 0.110 |
Why?
|
| GTP-Binding Protein gamma Subunits | 1 | 2014 | 15 | 0.110 |
Why?
|
| Nerve Growth Factor | 1 | 2014 | 29 | 0.110 |
Why?
|
| Neurites | 1 | 2014 | 40 | 0.110 |
Why?
|
| CHO Cells | 5 | 2014 | 123 | 0.110 |
Why?
|
| Manduca | 1 | 1994 | 10 | 0.110 |
Why?
|
| Tropanes | 1 | 2014 | 7 | 0.110 |
Why?
|
| Cricetinae | 5 | 2014 | 241 | 0.110 |
Why?
|
| Female | 3 | 2025 | 24698 | 0.110 |
Why?
|
| Receptors, Dopamine D4 | 1 | 2014 | 16 | 0.110 |
Why?
|
| Acrylamides | 1 | 2014 | 14 | 0.110 |
Why?
|
| Disease Models, Animal | 1 | 2000 | 1596 | 0.110 |
Why?
|
| Oxidopamine | 2 | 2006 | 23 | 0.100 |
Why?
|
| Metalloendopeptidases | 1 | 1993 | 15 | 0.100 |
Why?
|
| Microtubules | 1 | 2014 | 121 | 0.100 |
Why?
|
| Antipsychotic Agents | 1 | 2014 | 80 | 0.100 |
Why?
|
| Dopamine | 5 | 2006 | 275 | 0.100 |
Why?
|
| Caco-2 Cells | 1 | 2013 | 64 | 0.100 |
Why?
|
| Protein Precursors | 3 | 1998 | 59 | 0.100 |
Why?
|
| Indoles | 1 | 2014 | 187 | 0.090 |
Why?
|
| Perfume | 1 | 2012 | 2 | 0.090 |
Why?
|
| Proprotein Convertase 2 | 5 | 1999 | 19 | 0.090 |
Why?
|
| Amphetamine | 2 | 2003 | 21 | 0.090 |
Why?
|
| Edetic Acid | 3 | 1999 | 23 | 0.090 |
Why?
|
| Phenylmethylsulfonyl Fluoride | 1 | 2011 | 3 | 0.090 |
Why?
|
| Ascaridia | 1 | 1991 | 1 | 0.090 |
Why?
|
| Ascaridiasis | 1 | 1991 | 1 | 0.090 |
Why?
|
| Biogenic Amines | 1 | 1991 | 13 | 0.090 |
Why?
|
| Signal Transduction | 1 | 2021 | 2157 | 0.090 |
Why?
|
| Poultry Diseases | 1 | 1991 | 12 | 0.090 |
Why?
|
| Catalytic Domain | 1 | 2011 | 118 | 0.080 |
Why?
|
| Neuroendocrine Secretory Protein 7B2 | 4 | 1999 | 5 | 0.080 |
Why?
|
| Catalysis | 1 | 2011 | 187 | 0.080 |
Why?
|
| Enzyme Activation | 4 | 2006 | 462 | 0.080 |
Why?
|
| Neurons | 3 | 2014 | 1263 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2014 | 876 | 0.080 |
Why?
|
| Behavior, Animal | 2 | 2006 | 373 | 0.080 |
Why?
|
| Recombinant Proteins | 5 | 1999 | 518 | 0.080 |
Why?
|
| Central Nervous System Stimulants | 2 | 2003 | 180 | 0.080 |
Why?
|
| Oligopeptides | 3 | 1996 | 109 | 0.080 |
Why?
|
| Enkephalin, Leucine-2-Alanine | 3 | 1994 | 3 | 0.080 |
Why?
|
| Chickens | 1 | 1991 | 161 | 0.080 |
Why?
|
| Serine Proteinase Inhibitors | 2 | 2008 | 9 | 0.080 |
Why?
|
| Protein Conformation | 1 | 2010 | 416 | 0.080 |
Why?
|
| Molecular Weight | 3 | 1999 | 168 | 0.070 |
Why?
|
| Peptides | 3 | 1997 | 372 | 0.070 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2006 | 78 | 0.070 |
Why?
|
| Esters | 1 | 2008 | 25 | 0.070 |
Why?
|
| Male | 10 | 2006 | 23409 | 0.070 |
Why?
|
| Sequence Analysis, Protein | 1 | 2008 | 52 | 0.070 |
Why?
|
| Motor Activity | 3 | 2014 | 437 | 0.070 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2008 | 197 | 0.070 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 1997 | 465 | 0.070 |
Why?
|
| Enkephalins | 2 | 1998 | 31 | 0.070 |
Why?
|
| Insect Hormones | 3 | 1997 | 8 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 968 | 0.070 |
Why?
|
| Cathepsin D | 1 | 2006 | 16 | 0.060 |
Why?
|
| Juvenile Hormones | 1 | 2006 | 10 | 0.060 |
Why?
|
| Cystatins | 1 | 2006 | 19 | 0.060 |
Why?
|
| Drug Synergism | 2 | 2006 | 195 | 0.060 |
Why?
|
| Cysteine Endopeptidases | 1 | 2006 | 64 | 0.060 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 280 | 0.060 |
Why?
|
| Pulmonary Alveoli | 1 | 2026 | 28 | 0.060 |
Why?
|
| Paraquat | 1 | 2006 | 20 | 0.060 |
Why?
|
| MPTP Poisoning | 1 | 2006 | 12 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2026 | 95 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 1999 | 307 | 0.060 |
Why?
|
| Neurotoxins | 1 | 2006 | 57 | 0.060 |
Why?
|
| Ligands | 2 | 2019 | 388 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1999 | 388 | 0.060 |
Why?
|
| Drug Design | 1 | 2006 | 186 | 0.060 |
Why?
|
| PC12 Cells | 3 | 2014 | 93 | 0.060 |
Why?
|
| Lysophosphatidylcholines | 1 | 2004 | 22 | 0.050 |
Why?
|
| Cations, Divalent | 2 | 1994 | 25 | 0.050 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2005 | 140 | 0.050 |
Why?
|
| Hyperkinesis | 1 | 2003 | 7 | 0.050 |
Why?
|
| Temperature | 2 | 1996 | 313 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 2004 | 30 | 0.050 |
Why?
|
| Body Temperature | 1 | 2003 | 35 | 0.050 |
Why?
|
| Membrane Transport Proteins | 1 | 2004 | 100 | 0.050 |
Why?
|
| Culture Media, Conditioned | 2 | 2002 | 49 | 0.050 |
Why?
|
| Triazoles | 1 | 2003 | 102 | 0.050 |
Why?
|
| Mice | 6 | 2014 | 6644 | 0.050 |
Why?
|
| Methionine | 1 | 2002 | 27 | 0.050 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 224 | 0.050 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2001 | 3 | 0.040 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2001 | 18 | 0.040 |
Why?
|
| Levodopa | 1 | 2001 | 26 | 0.040 |
Why?
|
| Tyrosine | 1 | 2001 | 120 | 0.040 |
Why?
|
| Florida | 1 | 2023 | 478 | 0.040 |
Why?
|
| California | 1 | 2023 | 548 | 0.040 |
Why?
|
| Sympathectomy, Chemical | 1 | 2000 | 1 | 0.040 |
Why?
|
| Oxidative Stress | 1 | 2006 | 1003 | 0.040 |
Why?
|
| Stereotyped Behavior | 1 | 2000 | 23 | 0.040 |
Why?
|
| Freeze Drying | 1 | 2000 | 29 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 2014 | 109 | 0.040 |
Why?
|
| Enzyme Stability | 2 | 1996 | 34 | 0.040 |
Why?
|
| Sequence Analysis | 1 | 1999 | 26 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2002 | 638 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 1996 | 122 | 0.040 |
Why?
|
| Protease Inhibitors | 1 | 1999 | 54 | 0.040 |
Why?
|
| Time Factors | 2 | 2001 | 1857 | 0.040 |
Why?
|
| Cisplatin | 1 | 2019 | 98 | 0.040 |
Why?
|
| Transfection | 1 | 1999 | 532 | 0.030 |
Why?
|
| Cell Membrane | 2 | 2004 | 403 | 0.030 |
Why?
|
| Mammals | 2 | 1997 | 112 | 0.030 |
Why?
|
| Base Sequence | 2 | 1996 | 983 | 0.030 |
Why?
|
| Minority Groups | 1 | 2023 | 690 | 0.030 |
Why?
|
| Peptide Hydrolases | 1 | 1997 | 44 | 0.030 |
Why?
|
| Insect Proteins | 1 | 1997 | 53 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 182 | 0.030 |
Why?
|
| Calcium | 1 | 1999 | 491 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1996 | 39 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1996 | 68 | 0.030 |
Why?
|
| DNA Primers | 1 | 1996 | 294 | 0.030 |
Why?
|
| Binding Sites | 2 | 1996 | 671 | 0.030 |
Why?
|
| Cell Enlargement | 1 | 2014 | 6 | 0.030 |
Why?
|
| Catalepsy | 1 | 2014 | 9 | 0.030 |
Why?
|
| Apomorphine | 1 | 2014 | 13 | 0.030 |
Why?
|
| Cerebellum | 1 | 2014 | 79 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 2 | 2006 | 79 | 0.030 |
Why?
|
| Neurogenesis | 1 | 2014 | 63 | 0.030 |
Why?
|
| Octoxynol | 1 | 1994 | 19 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT2B | 1 | 2014 | 7 | 0.030 |
Why?
|
| Detergents | 1 | 1994 | 25 | 0.030 |
Why?
|
| Tubulin | 1 | 2014 | 96 | 0.030 |
Why?
|
| Receptor, Serotonin, 5-HT1A | 1 | 2014 | 17 | 0.030 |
Why?
|
| Cricetulus | 1 | 2014 | 82 | 0.030 |
Why?
|
| Pyrrolidonecarboxylic Acid | 1 | 1993 | 6 | 0.030 |
Why?
|
| Membranes | 1 | 1993 | 18 | 0.030 |
Why?
|
| Species Specificity | 1 | 1994 | 286 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 1994 | 108 | 0.030 |
Why?
|
| Glycopeptides | 1 | 1993 | 14 | 0.030 |
Why?
|
| Drosophila melanogaster | 1 | 1995 | 193 | 0.030 |
Why?
|
| S-Adenosylhomocysteine | 2 | 2002 | 11 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 1991 | 39 | 0.020 |
Why?
|
| Octopamine | 1 | 1991 | 9 | 0.020 |
Why?
|
| Hippocampus | 1 | 2014 | 594 | 0.020 |
Why?
|
| Acetylation | 1 | 1991 | 107 | 0.020 |
Why?
|
| Serotonin | 1 | 1991 | 123 | 0.020 |
Why?
|
| Sympatholytics | 1 | 2006 | 13 | 0.020 |
Why?
|
| Cystatin C | 1 | 2006 | 25 | 0.020 |
Why?
|
| Cathepsin B | 1 | 2006 | 35 | 0.020 |
Why?
|
| Homovanillic Acid | 1 | 2006 | 10 | 0.020 |
Why?
|
| Lysosomes | 1 | 2006 | 86 | 0.020 |
Why?
|
| 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | 1 | 2006 | 15 | 0.020 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 1 | 2006 | 27 | 0.020 |
Why?
|
| Reproduction | 1 | 2006 | 94 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2006 | 227 | 0.010 |
Why?
|
| Herbicides | 1 | 2006 | 43 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2006 | 456 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2006 | 210 | 0.010 |
Why?
|
| Mazindol | 1 | 2004 | 4 | 0.010 |
Why?
|
| Tritium | 1 | 2004 | 46 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 2004 | 65 | 0.010 |
Why?
|
| Dizocilpine Maleate | 1 | 2004 | 43 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 2004 | 59 | 0.010 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2004 | 59 | 0.010 |
Why?
|
| Receptors, Dopamine D1 | 1 | 2004 | 46 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2004 | 92 | 0.010 |
Why?
|
| Benzazepines | 1 | 2004 | 33 | 0.010 |
Why?
|
| Phospholipids | 1 | 2004 | 70 | 0.010 |
Why?
|
| Neuroprotective Agents | 1 | 2006 | 269 | 0.010 |
Why?
|
| Brain Chemistry | 1 | 2004 | 141 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 240 | 0.010 |
Why?
|
| Benzamides | 1 | 2004 | 81 | 0.010 |
Why?
|
| Dopamine Uptake Inhibitors | 1 | 2004 | 83 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 2004 | 121 | 0.010 |
Why?
|
| Intracellular Fluid | 1 | 2002 | 26 | 0.010 |
Why?
|
| Phylogeny | 1 | 2006 | 769 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 575 | 0.010 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2002 | 76 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2002 | 64 | 0.010 |
Why?
|
| DNA Fragmentation | 1 | 2002 | 98 | 0.010 |
Why?
|
| Enzyme Induction | 1 | 2001 | 52 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2002 | 152 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 257 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2006 | 1869 | 0.010 |
Why?
|
| Proteins | 1 | 2002 | 382 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2001 | 883 | 0.010 |
Why?
|
| Kidney | 1 | 2001 | 372 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2001 | 536 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 1996 | 41 | 0.010 |
Why?
|
| Proinsulin | 1 | 1996 | 1 | 0.010 |
Why?
|
| Proline | 1 | 1996 | 40 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 1998 | 1035 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1995 | 314 | 0.010 |
Why?
|
| Cell Line | 1 | 1996 | 1410 | 0.010 |
Why?
|